ArticleJournal of visualized experiments : JoVE2026
Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling.
Article in Journal of visualized experiments : JoVE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The plasma membrane defines the cell shape and serves as the interface that governs intercellular communication. Membrane proteins constitute a major class of therapeutic targets; therefore, super-resolving the cell membrane through its constitutive proteins holds great promise in advancing cell biology and antibody therapeutics. In this regard, single-molecule localization microscopy (SMLM) enables nanoscale visualization of protein organizations on biological structures. Despite its importance, applying SMLM to plasma membrane proteins poses unique challenges. In this protocol, we present an effective approach using time-lapse single-antibody labeling (SAL) termed membrane SAL (mSAL). We provide detailed step-by-step instructions, including optimization of the antibody concentration, laser power density, duration of non-illumination intervals, image reconstruction, and density-based cluster analysis, to resolve nanoscale membrane protein distribution and membrane morphology. We use the tetraspanin protein CD81 as the model membrane protein to demonstrate the capability of mSAL on both adherent and suspension mammalian cells. In addition to super-resolving the cell membrane and distributions of membrane proteins, our technique enables the investigation of the pharmacodynamics of therapeutic antibodies interacting with their membrane targets in the native membrane environment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.